Kronos Bio, Inc. (KRON) NASDAQ

0.88

+0.0129(+1.49%)

Updated at June 20 04:00PM

Currency In USD

Valuation

Market Cap57.07M
Enterprise Value-2.6M
P/E Ratio-0.83
PEG Ratio-0.03
Price/Sales Ratio5.84
Price/Book Ratio0.67
Enterprise/Revenue-1.51
Enterprise/EBITDA0.28

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-7.02
Operating Margin-7.65

Management Effectiveness

Return On Assets-0.6
Return On Equity-0.64

Income Statement

Revenue9.85M
Revenue/Share0.15
Gross Profit9.85M
EBITDA-61.72M
Net Income-86.08M
Diluted EPS-1.43

Balance Sheet

Total Cash99.73M
Total Cash/Share1.64
Total Debt24.09M
Total Debt/Equity0.3
Current Ratio12.93
Book Value Per Share1.31

Price History

52-Week Change-29.6
52-Week High1.46
52-Week Low0.65
Moving Average 50 Days0.8
Moving Average 200 Days0.9

Statistics

Average Volume855,959
Shares Outstanding60.97M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A